ABOUT US

We Focus on Identifying, Acquiring and Developing Disease Modifying Therapeutic Drug Candidates with a Concentration on Rare Disease Indications

At Curative Biotech, our unique business model coupled with our deep industry leadership experience enables us to build a pipeline of first in class drugs with accelerated development pathways to address the unmet medical needs of patients.

Pipeline

We currently have eight ongoing programs in three therapeutic areas:

All our programs are currently focused on orphan indications; however, the mechanisms of action we are targeting will likely allow us to expand the use of these drugs in the future to non-orphan indications.

Infectious Disease

Neuro Oncology

Degenerative Eye Disease

STOCK INFORMATION

CUBT Stock Price

*Quotes on stock price are delayed and not real-time.